TGF-β1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells

Genes and Development

Volumn 10, Issue 19, 1996, Pages 2462-2477

  Oft, Martin ^a   Peli, Janos ^b   Rudaz, Claude ^b   Schwarz, Heinz ^c   Beug, Hartmut ^a   Reichmann, Ernst ^b  

^a RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

^b SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

^c MAX PLANCK INSTITUTE FOR DEVELOPMENTAL BIOLOGY   (Germany)

Author keywords

autocrine loop; cell invasion; Mammary epithelial cells; phenotypic plasticity; Ras; TGF

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1; COLLAGEN; GROWTH PROMOTOR; MESSENGER RNA; PROTEIN P21; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANIMAL CELL; ARTICLE; BREAST CARCINOGENESIS; CANCER INVASION; CELL TRANSFORMATION; EPITHELIUM TUMOR; GROWTH REGULATION; MALIGNANT TRANSFORMATION; METASTASIS POTENTIAL; MOUSE; NONHUMAN; ONCOGENE H RAS; PLASTICITY; PRIORITY JOURNAL; TUMOR GROWTH; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; CELL LINE; CELL POLARITY; CHICK EMBRYO; CYTOLOGY; EPITHELIUM CELL; EXPERIMENTAL NEOPLASM; FIBROBLAST; GEL; GENETICS; HEART; NEOPLASM; NUDE MOUSE; ONCOGENE RAS; PATHOLOGY; PHYSIOLOGY; UDDER; UPREGULATION;

ANIMALIA;

ANIMALS; CELL LINE, TRANSFORMED; CELL POLARITY; CELL TRANSFORMATION, NEOPLASTIC; CHICK EMBRYO; COLLAGEN; EPITHELIAL CELLS; FIBROBLASTS; GELS; GENES, RAS; GROWTH SUBSTANCES; HEART; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASMS, GLANDULAR AND EPITHELIAL; ONCOGENE PROTEIN P21(RAS); RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0029662049     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.10.19.2462     Document Type: Article

References (78)

1. Antonelli-Orlidge, A., K.B. Saunders, S.R. Smith, and P.A. D'Amore. 1989. An activated form of transforming growth factor β is produced by cocultures of endothelial cells and pericytes. Proc. Natl. Acad. Sci. 86: 4544-4548.
2. Aznavoorian, S., A.N. Murphy, S.W. Stetler, and L.A. Liotta. 1993. Molecular aspects of tumor cell invasion and metastasis. Cancer 71: 1368-1383.
3. Behrens, J., L. Vakaet, R. Friis, E. Winterhager, R.F. Van, M.M. Marcel, and W. Birchmeier. 1993. Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/beta-catenin ex in cells transformed with a temperature-sensitive v-SRC gene. J. Cell Biol. 120: 757-766.
4. Birchmeier, W., K.M. Weidner, and J. Behrens. 1993. Molecular mechanisms leading to loss of differentiation and gain of invasiveness in epithelial cells. J. Cell Sci. [Suppl.] 17: 159-164.
5. Border, A.I. and V. Ruoslahti. 1992. Transforming Growth Factor-β in disease: The dark side of tissue repair. J. Clin. Invest. 90: 1-7
6. Bos, J.L. 1989. Ras oncogenes in human cancer, a review. Cancer Res. 49: 4682-4689.
7. Boyer, B., S. Dufour, and J.P. Thiery. 1992. E-cadherin expression during the acidic FGF-induced dispersion of a rat bladder carcinoma cell line. Exp. Cell Res. 201: 347-357.
8. Buchmann, A., B. Ruggeri, S.A. Klein, and A. Balmain. 1991. Progression of squamous carcinoma cells to spindle carcinomas of mouse skin is associated with an imbalance of H-ras alleles on chromosome 7. Cancer Res. 51: 4097-4101.
9. Castle, V., J. Varani, S. Fligiel, E.V. Prochownik, and V. Dixit. 1991. Antisense-mediated reduction in thrombospondin reverses the malignant phenotype of a human squamous carcinoma. J. Clin. Invest. 87: 1883-1888.
10. Caulin, C., F.G. Scholl, P. Frontelo, C. Gamallo, and M. Quintanilla. 1995. Chronic exposure of cultured transformed epidermal cells to transforming growth factor β1 induces an epithelial-mesenchymal transdifferentiation and a spindle tumoral phenotype. Cell Growth Differ. 6: 1027-1035.
11. Chomczynski, P. and N. Sacchi. 1987. Single-step method of RNA isolation by acid ganidinium thiocyanate - phenol chloroform extraction. Anal. Biochem. 162: 156-159.
12. Clark, G.J. and C.J. Der. 1995. Aberrant function of the Ras signal transduction pathway in human breast cancer. Breast Cancer Res. Treat. 35: 133-144.
13. De Bortoli, M., H. Abou-Issa, B.E. Haley, and Y.S. Cho-Chung. 1985. Amplified expression of p21RAS protein in hormone-dependent mammary carcinomas of human and rodents. Biochem. Biophys. Res. Commun. 127: 699-706.
14. Derynck, R., J.A. Jarret, E.Y. Chen, D.H. Eaton, J.R. Bell, R.K. Assoian, A.B. Roberts, M.B. Sporn, and D.V. Goeddel. 1985. Human transforming growth factor beta complementary DNA sequence and expression in normal and transformed cells. Nature 316: 701-705.
15. Dvorak, H.F. 1986. Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 315: 1650-1659.
16. Eaton, S. and K. Simons. 1995. Apical, basal, and lateral cues for epithelial polarization. Cell 82: 5-8.
17. Edwards, D.R., G. Murphy, J.J. Reynolds, S.E. Whitham, A.J.P. Docherty, P. Angel, and J.K. Heath. 1987. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J. 6: 1899-1904.
18. Fearon, E.R. and B. Vogelstein. 1990. A genetic model for colorectal tumorigenesis. Cell 61: 759-767.
19. Fialka, I., H. Schwarz, E. Reichmann, M. Busslinger, and H. Beug. 1996. The estrogen dependent c-JunER protein causes a reversible loss of mammary epithelial cell polarity involving a destabilization of adherens junctions. J. Cell Biol. 132: 1115-1132.
20. Frisch, S.M. and H. Francis. 1994. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 24: 619-626.
21. Fynan, T.M. and M. Reiss. 1993. Resistance to inhibition of cell growth by transforming growth factor beta and its role in oncogenesis. Grit. Rev. Oncog. 4: 493-540.
22. Gabbert, H., R. Wagner, R. Moll, and C.D. Gerharz. 1985. Tumor dedifferentiation, an important step in tumor invasion. Clin. Expl. Metastasis 3: 257-279.
23. Guldberg, G. 1923. Changes in the skin and organs in white mice after painting with tar. Acta Pathol. Microbiol. Scand. 4: 276-284.
24. Hand, P., A. Thor, D. Wunderlich, R. Maurano, A. Caruso, and J. Schlom. 1984. Monoclonal antibodies of pre-defined specificity detect activated RAS gene expression in human mammary and colon carcinogenesis. Proc. Natl. Acad. Sci. 81: 5227-5231.
25. Hartmann, G., K.M. Weidner, H. Schwarz, and W. Birchmeier. 1994. The motility signal of scatter factor/hepatocyte growth factor mediated through the receptor tyrosine kinase met requires intracellular action of Ras. J. Biol. Chem. 269: 21936-21939.
26. Hayman, M.J., S. Meyer, F. Martin, P. Steinlein, and H. Beug. 1993. Self renewal and differentiation of normal avian erythroid progenitor cells: Regulatory roles of the c-erbB/TGFα receptor and the c-kit /SCF receptor. Cell 74: 157-169.
27. Hoosein, N.M., M.K. McKnight, A.E. Levine, K.M. Mulder, K.E. Childress, D.E. Brattain, and M.G. Brattain. 1989. Differential sensitivity of subclasses of human colon carcinoma cell lines to the growth inhibitory effects of transforming growth factor-beta 1. Exp. Cell Res. 181: 442-453.
28. Kern, F.G., A.L. Cheville, and Y.L. Liu. 1990. Growth factor receptors and the progression of breast cancer. Semin. Cancer Biol 1: 317-328.
29. Keski-Oja, J., E.B. Loef, R.M. Lyons, R.J.J. Coffey, and H.L. Moses. 1987. Transforming growth factor and control of neoplastic cell growth. J. Cell. Biochem. 33: 95-107.
30. Kim, S.J., K.T. Jeang, A.B. Glick, M.B. Sporn, and A.B. Roberts. 1989. Promoter sequences of the human transforming growth factor-β1 gene responsive to transforming growth factor β1 autoinduction. J. Biol. Chem. 264: 7041-7045.
31. Kraus, M.H., Y. Yuasa, and S.A. Aaronson. 1984. A position 12-activated Ha-ras oncogene in all HS578T mammary carcinosarcoma cells but not normal mammary cells of the same patient. Proc. Natl. Acad. Sci. 81: 5384-5388.
32. LaBonne, C. and M. Whitman. 1994. Mesoderm induction by activin requires FGF-mediated intercellular signals. Development 120: 463-472.
33. Laiho, M., O. Saksela, and J. Keski-Oja. 1987. Transforming growth factor-β induction of type 1 plasminogen activator inhibitor. J. Biol. Chem. 262: 17467-17474.
34. Land, H., L.F. Parada, and R.A. Weinberg. 1983. Tumorigenic conversion of primary embryo fibroblasts require at least two cooperating oncogenes. Nature 304: 596-602.
35. LeJeune, S., R. Leek, E. Horak, G. Plowman, M. Greenall, and A.L. Harris. 1993. Amphiregulin, epidermal growth factor receptor, and estrogen receptor expression in human primary breast cancer. Cancer Res. 53: 3597-3602.
36. Leonard, M.W., K.C. Lim, and J.D. Engel. 1993. Expression of the chicken GATA factor family during early erythroid development and differentiation. Development 119: 519-531.
37. Liotta, L.A. and W.G. Stetler-Stevenson. 1991. Tumor invasion and metastasis: An imbalance of positive and negative regulation. Cancer Res. 51: 5054-5059.
38. Liotta, L.A., P.S. Steeg, and W.G. Stetler-Stevenson. 1991. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 64: 327-336.
39. Macauley, A. and T. Pawson. 1988. Cooperative transforming activity of ras, myc and src viral oncogenes in nonestablished rat adrenocortical cells. J. Virol. 62: 4712-4721.
40. Maniatis, T., E.F. Fritsch, and J. Sambrook. 1982. Molecular cloning: A laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
41. Mareel, M.M. 1980. Recent aspects of tumor invasiveness. Int. Rev. Exp. Pathol. 22: 65-129.
42. _. 1983. Invasion in vitro. Cancer Metastasis Rev. 2: 201-218.
43. Mareel, M., J. Kint, and C. Meyvisch. 1979. Methods of study of the invasion of malignant C3H mouse fibroblasts into embryonic chick heart in vitro. Virchows Arch. (B) 30: 95-111.
44. Mareel, M.M., J. Behrens, W. Birchmeier, G.K. De Bruyne, K. Vleminckx, A. Hoodgewus, W.C. Fiers, and F.M. Van Roy. 1991. Down-regulation of E-cadherin expression in Madin Darby canine kidney (MDCK) cells inside tumors of nude mice. Int. J. Cancer 47: 922-928.
45. Miettinen, P.J., R. Ebner, A.R. Lopez, and R. Derynck. 1994. TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: Involvement of type I receptors. J. Cell Biol. 127: 2021-2036.
46. Murthy, U., M.A. Anzano, and R.G. Creig. 1989. Expression of TGF-alpha/EGF and TGF-beta receptors in human colon carcinoma cell lines. Int. J. Cancer 44: 110-115.
47. Parker, T.G., S.E. Packer, and M.D. Schneider. 1990. Peptide growth factors can provoke "fetal" contractile protein gene expression in rat cardiac myocytes. J. Clin. Invest. 85: 507-514.
48. Payne, A., E.N. Olson, P. Hsiau, R. Roberts, M.B. Perryman, and M.D. Schneider. 1987. An activated c-Ha-ras allele blocks the induction of muscle-specific genes whose expression is contingent on mitogen withdrawal. Proc. Natl. Acad. Sci. 84: 8956-8960.
49. Pereira-Smith, O.M. and J. Smith. 1988. Genetic analysis of indefinite division in human cells: Identification of four complementation groups. Proc. Natl. Acad. Sci. 85: 6042-6046.
50. Powell, S.M., G.M. Petersen, A.J. Krush, S. Booker, I. Jen, F.M. Giardiello, S.R. Hamilton, B. Vogelstein, and K.W. Kinzler. 1993. Molecular diagnosis of familial adenomatous polyposis. N. Engl. J. Med. 329: 1982-1987.
51. Redmond, S.M., E. Reichmann, R.G. Mueller, R.R. Friis, B. Groner, and N.E. Hynes. 1988. The transformation of primary and established mouse mammary epithelial cells by p21-Ras is concentration dependent. Oncogene 2: 259-265.
52. Reichmann, E. 1994. Oncogenes and epithelial cell transformation. Sem. Cancer Biol. 5: 157-165.
53. Reichmann, E., R. Ball, B. Groner, and R.R. Friis. 1989. New mammary epithelial and fibroblastic clones in coculture form structures competent to differentiate functionally. J. Cell Biol 108: 1127-1138.
54. Reichmann, E., H. Schwarz, E.M. Deiner, I. Leitner, M. Eilers, J. Berger, M. Busslinger, and H. Beug. 1992. Activation of an inducible c-FosER fusion protein causes loss of epithelial polarity and triggers epithelial-fibroblastoid cell conversion. Cell 71: 1103-1116.
55. Roberts, A.B. and M.B. Sporn. 1992. Mechanistic interrelationships between two superfamilies: The steroid/retinoid receptors and transforming growth factor-beta. Cancer Surv. 14: 205-220.
56. Roberts, A.B., M.B. Sporn, R.K. Assoian, J.M. Smith, N.S. Roche, L.M. Wakefield, U.I. Heine, L.A. Liotta, V. Falanga, J.H. Kehrl, and A.S. Fauci. 1986. Transforming growth factor type β: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. 83: 4167-4171.
57. Sandford, K.K., T.B. Dunn, B.B. Westfall, B.B. Covalesky, A.B. Covalesky, L.T. Dupree, and W.R. Earle. 1961. Sarcomatous change and maintenance of differentiation in long-term cultures of mouse mammary carcinomas. J. Natl. Cancer Inst. 26: 1139-1193.
58. Sato, Y., R. Tsuboi, R. Lyons, H. Moses, and D.B. Rifkin. 1990. Characterization of the activation of latent TGF-beta by cocultures of endothelial cells and pericytes or smooth muscle cells: A self-regulating system. J. Cell Biol. 111: 757-763.
59. Schoenenberger, C.A., A. Zuk, G.M. Zinkl, D. Kendall, and K.S. Matlin. 1994. Integrin expression and localization in normal MDCK cells and transformed MDCK cells lacking apical polarity. J. Cell Sci. 107: 527-541.
60. Schultz-Cherry, S., S. Ribeiro, L. Gentry, and J.E. Murphy-Ullrich. 1994. Thrombospondin binds and activates the small and large forms of latent transforming growth factor-beta in a chemically defined system. J. Biol. Chem. 269: 26775-26782.
61. Schwarz, H. 1994. Immunolabelling of ultrathin resin sections for immunofluorescence and electron microscopy. In Electron microscopy 1994 ICEM (ed. B. Jouffrey and C. Colliex), Vol. 63, pp. 255-256. Les editions de physique, Les Ulis, Paris, France.
62. Schwarz, H., A. Mueller-Schmidt, and W. Hoffmann. 1993. Ultrastructural localization of ependymins in the endomeninx of the brain of the rainbow trout: Possible association with collagen fibrils of the extracellular matrix. Cell Tissue Res. 273: 417-425.
63. Slamon, D.J., J.B. de Kernion, I.M. Verma, and M.J. Cline. 1984. Expression of cellular oncogenes in human malignancies. Science 224: 256-262.
64. Sonnenberg, A., H. Daams, J. Calafat, and J. Hilgers. 1986. In vitro differentiation and progression of mouse mammary tumor cells. Cancer Res. 46: 5913-5922.
65. Soriano, J.V., M.S. Pepper, T. Nakamura, L. Orci, and R. Montesano. 1995. Hepatocyte growth factor stimulates extensive development of branching duct-like structures by cloned mammary gland epithelial cells. J. Cell Sci. 108: 413-430.
66. Stoler, A.B., F. Stenback, and A. Balmain. 1993. The conversion of mouse skin squamous cell carcinomas to spindle cell carcinomas is a recessive event. J. Cell Biol. 122: 1103-1117.
67. Strange, R., F. Li, R.R. Friis, E. Reichmann, B. Haenni, and P.H. Burn. 1991. Mammary epithelial differentiation in vitro: Minimum requirements for a functional response to hormonal stimulation. Cell. Growth Differ. 2: 549-559.
68. Thompson, A.M., D.J. Kerr, and C.M. Steel. 1991. Transforming growth factor beta 1 is implicated in the failure of tamoxifen therapy in human breast cancer. Br. J. Cancer 63: 609-614.
69. Thompson, T.C., L.D. Truong, T.L. Timme, D. Kadmon, B.K. McCune, K.C. Flanders, P.T. Scardino, and S.H. Park. 1992. Transforming growth factor beta 1 as a biomarker for prostate cancer. J. Cell. Biochem. (Suppl.) 16H: 54-61.
70. _. 1993. Transgenic models for the study of prostate cancer. Cancer (Suppl.) 71: 1165-1171.
71. Thorburn, A., J. Thorburn, S.Y. Chen, S. Powers, H.E. Shubeita, J.R. Feramisco, and K.R. Chien. 1993. HRas-dependent pathways can activate morphological and genetic markers of cardiac muscle cell hypertrophy. J. Biol. Chem. 268: 2244-2249.
72. Umbhauer, M., C.J. Marshall, C.D. Mason, R.K. Old, and J.C. Smith. 1995. Mesoderm induction in Xenopus caused by activation of MAP kinase. Nature 376: 58-62.
73. Vogelstein, B. and K.W. Kinzler. 1993. The multistep nature of cancer. Trends Genet. 9: 138-141.
74. Welch, D.R., A. Fabra, and M. Nakajima. 1990. Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential. Proc. Natl. Acad. Sci. 87: 7678-7682.
75. Whitman, M. and D.A. Melton. 1992. Involvement of p21ras in Xenopus mesoderm induction. Nature 357: 252-254.
76. Wong, S.Y., A.T. Purdie, and P. Han. 1992. Thrombospondin and other possible related matrix proteins in malignant and benign breast disease. An immunohistochemical study. Am. J. Pathol. 140: 1473-1482.
77. Wright, J.H., S. McDonnell, G. Portella, G.T. Bowden, A. Balmain, and L.M. Matrisian. 1994. A switch from stromal to tumor cell expression of stromelysin-1 mRNA associated with the conversion of squamous to spindle carcinomas during mouse skin tumor progression. Mol. Carcinog. 10: 207-215.
78. Zambruno, G., P.C. Marchisio, A. Marconi, C. Vaschieri, A. Melchiori, A. Giannetti, and M. De Luca. 1995. Transforming growth factor-beta 1 modulates beta 1 and beta 5 integrin receptors and induces the de novo expression of the alpha v beta 6 heterodimer in normal human keratinocytes: Implications for wound healing. J. Cell Biol. 129: 853-865.